Valentina Marchica
Parma, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma.
Journal: Haematologica
Published: March 24, 2023
Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma.
Journal: bioRxiv : the preprint server for biology
Published: March 03, 2023
The impact of CD56 expression in smoldering myeloma patients on early progression.
Journal: Hematological oncology
Published: November 28, 2022
Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma.
Journal: International journal of molecular sciences
Published: November 11, 2022
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response.
Journal: Oncoimmunology
Published: September 15, 2022
Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease.
Journal: Frontiers in oncology
Published: August 09, 2022
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.
Journal: Nature communications
Published: July 29, 2022
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
Journal: Nature medicine
Published: April 28, 2022
Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets.
Journal: Cells
Published: May 11, 2021
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma.
Journal: Frontiers in oncology
Published: March 23, 2021
Last Updated: 09/26/2026